Cargando…
Evaluating the Safety of Intranasal Steroids in the Treatment of Allergic Rhinitis
Given that intranasal corticosteroids (INCs) are widely considered first-line therapies for treatment of rhinitis, it is important for the clinician to be comfortable with the side-effect profile and be able to discuss potential safety concerns regarding these therapies. Among the safety concerns wi...
Autor principal: | Sheth, Ketan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868867/ https://www.ncbi.nlm.nih.gov/pubmed/20525134 http://dx.doi.org/10.1186/1710-1492-4-3-125 |
Ejemplares similares
-
Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008) -
Novel mouse model of steroid-resistant allergic rhinitis by repeated intranasal administration of OVA
por: Izumi, Kazunari, et al.
Publicado: (2015) -
Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis
por: Bridgeman, Mary Barna
Publicado: (2017) -
Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis
por: Chennakeshavaraju, Nandish, et al.
Publicado: (2020) -
Effects of Topical Intranasal Doxycycline Treatment in the Rat Allergic Rhinitis Model
por: Avincsal, Mehmet Ozgür, et al.
Publicado: (2014)